Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess.
The innate immune response is supposed to play an essential role in the control of amebic liver abscess (ALA), a severe form of invasive amoebiasis due to infection with the protozoan parasite Entamoeba histolytica. In a mouse model for the disease, we previously demonstrated that Jalpha18(-/-) mice, lacking invariant natural killer T (iNKT) cells, suffer from more severe abscess development. Here we show that the specific activation of iNKT cells using alpha-galactosylceramide (alpha-GalCer) induces a significant reduction in the sizes of ALA lesions, whereas CD1d(-/-) mice develop more severe abscesses. We identified a lipopeptidophosphoglycan from E. histolytica membranes (EhLPPG) as a possible natural NKT cell ligand and show that the purified phosphoinositol (PI) moiety of this molecule induces protective IFN-gamma but not IL-4 production in NKT cells. The main component of EhLPPG responsible for NKT cell activation is a diacylated PI, (1-O-[(28:0)-lyso-glycero-3-phosphatidyl-]2-O-(C16:0)-Ins). IFN-gamma production by NKT cells requires the presence of CD1d and simultaneously TLR receptor signalling through MyD88 and secretion of IL-12. Similar to alpha-GalCer application, EhLPPG treatment significantly reduces the severity of ALA in ameba-infected mice. Our results suggest that EhLPPG is an amebic molecule that is important for the limitation of ALA development and may explain why the majority of E. histolytica-infected individuals do not develop amebic liver abscess.
Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany. lotter@bni-hamburg.de
Hannelore
H
Lotter
Nestor
N
González-Roldán
Buko
B
Lindner
Florian
F
Winau
Armando
A
Isibasi
Martha
M
Moreno-Lafont
Artur J
AJ
Ulmer
Otto
O
Holst
Egbert
E
Tannich
Thomas
T
Jacobs
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D055610:Antigens, CD1d / Q000235:genetics; D000953:Antigens, Protozoan / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004748:Entamoeba histolytica / Q000276:immunology* / Q000472:pathogenicity*; D005699:Galactosylceramides / Q000276:immunology; D007371:Interferon-gamma / Q000276:immunology; D008101:Liver Abscess, Amebic / Q000276:immunology* / Q000469:parasitology; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D055611:Natural Killer T-Cells / Q000276:immunology*; D010457:Peptidoglycan / Q000276:immunology*; D010716:Phosphatidylinositols / Q000737:chemistry; D010743:Phospholipids / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology; D053058:Trophozoites / Q000276:immunology
D055610:Antigens, CD1d; D000953:Antigens, Protozoan; D000954:Antigens, Surface; C526879:Cd1d1 protein, mouse; D005699:Galactosylceramides; D010457:Peptidoglycan; D010716:Phosphatidylinositols; D010743:Phospholipids; C493154:alpha-galactosylceramide; C014643:lipopeptidophosphoglycan; D007371:Interferon-gamma